ACW 3.70% 2.6¢ actinogen medical limited

I am a victim of Alzheimers and I have been following the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,614 Posts.
    lightbulb Created with Sketch. 1091
    I am a victim of Alzheimers and I have been following the journey of a range of multinationals searching for a result.

    Several companies are at the forefront of developing treatments for Alzheimer’s disease.

    Some of the notable ones include:
    Eli Lilly: They are working on drugs like donanemab, which targets amyloid plaques in the brain1.Biogen: Known for their drug aducanumab, which also targets amyloid plaques

    Eisai: Collaborating with Biogen on lecanemab, another amyloid-targeting drug1.Denali Therapeutics: Focused on neurodegenerative diseases with a strong pipeline for Alzheimer’s

    Amylyx Pharmaceuticals: Specializes in solutions for Alzheimer’s and other brain diseases2.

    These companies are making significant strides, however developing a cure for Alzheimer’s remains a complex challenge

    It is refreshing to see a local company joining the effort

    V

 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.